Notice2023-01160
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 23, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 14 (Monday, January 23, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 14 (Monday, January 23, 2023)]
[Notices]
[Pages 3990-3991]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-01160]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-1283]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Monitoring and Reporting for the Overdose
Data to Action Cooperative Agreement'' to the Office of Management and
Budget (OMB) for review and approval. CDC previously published a
``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on September 7, 2022, to obtain comments from
the public and affected agencies. CDC received one comment related to
the previous notice. This notice serves to allow an additional 30 days
for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Monitoring and Reporting for the Overdose Data to Action
Cooperative Agreement (OMB Control No. 0920-1283, Exp. 01/31/2023)--
Revision--National Center for Injury Prevention and Control (NCIPC),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
This is a Revision request for the currently approved Monitoring
and reporting for the Overdose Data to Action Cooperative Agreement
(OMB Control No. 0920-1283). In 2020, a total of 91,799 drug overdose
deaths occurred in the United States; the age-adjusted rate in 2020 was
31% higher than the rate in 2019. Approximately 75% of drug overdose
deaths in 2020 involved an opioid, and opioid overdose deaths in 2020
were 8.5 times the number they were in 1999. In addition, opioids are
nested in a broadening polysubstance crisis, largely driven by deaths
co-involving opioids and stimulants, such as cocaine and
methamphetamine. While the overdose epidemic worsens in scope and
magnitude, it is also becoming more complex.
In response to the growing severity of the opioid overdose
epidemic, the U.S. government declared the opioid overdose epidemic a
Public Health Emergency (PHE) on October 26, 2017, joining at least
eight states that have declared the opioid overdose epidemic a
statewide emergency. The opioid overdose epidemic is one of the U.S.
Department of Health and Human Services (HHS) top priorities. In 2017,
HHS launched a five-point Opioid Strategy: (1) Access: Better
Prevention, Treatment, and Recovery Services; (2) Data: Better Data on
the Epidemic; (3) Pain: Better Pain Management; (4) Overdoses: Better
Targeting of Overdose-Reversing Drugs; and (5) Research: Better
Research on Pain and Addiction.
CDC's overdose surveillance and prevention efforts include the
Overdose Data to Action (OD2A) cooperative agreement. The purpose of
OD2A is to support funded jurisdictions in obtaining high quality,
complete, and timelier data on opioid prescribing and overdoses
involving opioids, stimulants, and polysubstance use, and to use those
data to inform prevention and response efforts. The OD2A cooperative
agreement, ending in August 2023, will be followed by two fundings
aimed at reducing non-fatal and fatal overdoses; one will be focused on
states and the other on localities. OD2A in States (OD2A-S) will focus
on overdose surveillance and prevention efforts by state health
departments and Washington, DC, while OD2A Limiting Overdose through
Collaborative Actions in Localities (OD2A-LOCAL), will focus on
overdose surveillance and prevention efforts by city and county health
departments, and territories. These two cooperative agreements will
allow funded jurisdictions to continue the work started in OD2A and
adapt their overdose surveillance and
[[Page 3991]]
prevention efforts to the rapidly changing drug epidemic.
This is a Revision request for the currently approved Information
Collection Request (ICR) to continue the collection of information from
jurisdictions (which include states, Washington, DC, U.S. Territories,
cities, and counties), collect new information from jurisdictions
(which include states and Washington, DC), and collect new information
from jurisdictions (which include U.S. Territories, cities, and
counties) funded under the OD2A-LOCAL. All jurisdictions funded by the
OD2A NOFOs will report activity progress and capacity and workplan
updates using web-based tools.
Information collected will provide crucial data for program
performance monitoring, budget tracking, and where applicable, program
success. The information will also improve communication between CDC
and funding recipients as well as inform technical assistance and
guidance documents.
CDC requests OMB approval for an estimated 1,343 annualized burden
hours. There are no costs to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
OD2A-funded state, territory, county, Evaluation and 66 1 4
and city health departments. Performance Measuring
Plan Template.
Overdose Prevention 66 1 20/60
Capacity Assessment
Tool.
Annual Performance 66 1 40/60
Report.
OD2A-S-funded state and District of OD2A-S Annual 51 1 11
Columbia health departments. Performance Report and
Work Plan.
OD2A-S Evaluation & 51 1 20/60
Performance Measurement
Plan Template.
OD2A-S Data Management 51 1 40/60
Plan.
OD2A-LOCAL-funded territory, county, OD2A-LOCAL Annual 40 1 9
and city health departments. Performance Report and
Work Plan.
OD2A-LOCAL Evaluation & 40 1 20/60
Performance Measurement
Plan Template.
OD2A-LOCAL Data 40 1 40/60
Management Plan.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2023-01160 Filed 1-20-23; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on January 23, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.